Unknown

Dataset Information

Evaluation of Cancer-Based Criteria for Use in Mainstream BRCA1 and BRCA2 Genetic Testing in Patients With Breast Cancer.


ABSTRACT:

Importance

Increasing BRCA1 and BRCA2 (collectively termed herein as BRCA) gene testing is required to improve cancer management and prevent BRCA-related cancers.

Objective

To evaluate mainstream genetic testing using cancer-based criteria in patients with cancer.

Design, setting, and participants

A quality improvement study and cost-effectiveness analysis of different BRCA testing selection criteria and access procedures to evaluate feasibility, acceptability, and mutation detection performance was conducted at the Royal Marsden National Health Service Foundation Trust as part of the Mainstreaming Cancer Genetics (MCG) Programme. Participants included 1184 patients with cancer who were undergoing genetic testing between September 1, 2013, and February 28, 2017.

Ma

SUBMITTER: Kemp Z 

PROVIDER: S-EPMC6632150 | biostudies-literature | 2019 May

REPOSITORIES: biostudies-literature